Neurocrine Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NBIX Nasdaq 2836 http://www.neurocrine.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurocrine Biosciences, Inc.

Neurocrine Biosciences Officially Begins Marketing Its New Parkinson's Disease Drug - Sep 14th, 2020 5:24 pm
Neurocrine Biosciences Announces Once-Daily ONGENTYS® (opicapone) Now Available in the U.S. as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes - Sep 14th, 2020 12:43 pm
Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease - Sep 14th, 2020 12:30 pm
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy - Sep 11th, 2020 7:27 pm
Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson’s Disease - Sep 11th, 2020 3:36 pm
Neurocrine Biosciences Presents New Data Analyses Demonstrating Efficacy of FDA-Approved Once-Daily ONGENTYS® (opicapone) in Patients with Parkinson's Disease at the MDS Virtual Congress 2020 - Sep 11th, 2020 3:34 pm
Neurocrine Biosciences (NBIX): Hedge Funds In Wait-and-See Mode - Sep 10th, 2020 1:48 am
Neurocrine Biosciences (NASDAQ:NBIX) Shareholders Have Enjoyed An Impressive 102% Share Price Gain - Sep 9th, 2020 7:12 pm
Neurocrine Biosciences to Present at the Morgan Stanley 18th Annual Global Healthcare Conference - Sep 8th, 2020 8:01 pm
Neurocrine Biosciences to Present New Data from its Movement Disorder Programs for Tardive Dyskinesia and Parkinson's Disease at Upcoming Scientific Meetings - Sep 3rd, 2020 8:06 pm
Neurocrine Biosciences to Present at the Citi 15th Annual BioPharma Virtual Conference - Sep 2nd, 2020 8:01 pm
Looking Into Neurocrine Biosciences's Return On Capital Employed - Aug 28th, 2020 2:11 pm
Neurocrine Biosciences Inc (NBIX) Q2 2020 Earnings Call Transcript - Aug 4th, 2020 1:30 pm
How Is Neurocrine Biosciences' (NASDAQ:NBIX) CEO Paid Relative To Peers? - Aug 4th, 2020 12:38 pm
How Neurocrine Biosciences Crushed It in Q2 - Aug 4th, 2020 10:34 am
Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates - Aug 3rd, 2020 9:15 pm
Neurocrine Biosciences Stock Pops After Earnings Double, Shatter Views - Aug 3rd, 2020 8:37 pm
Neurocrine Biosciences Reports Second Quarter 2020 Financial Results - Aug 3rd, 2020 8:01 pm
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference 2020 - Jul 30th, 2020 8:01 pm